Megaloblastic anaemia occurring during treatment of epilepsy with phenytoin sodium, primidone and phenobarbitone.
D000740:Anemia / Q000209:etiology*; D000749:Anemia, Megaloblastic; D000927:Anticonvulsants / Q000009:adverse effects*; D004827:Epilepsy / Q000628:therapy*; D006801:Humans; D006827:Hydantoins / Q000009:adverse effects*; D010634:Phenobarbital / Q000009:adverse effects*; D010672:Phenytoin; D011324:Primidone
D000927:Anticonvulsants; D006827:Hydantoins; D011324:Primidone; D010672:Phenytoin; D010634:Phenobarbital
ANEMIA, HYPERCHROMIC/etiology and pathogenesis; ANTICONVULSANTS/injurious effects; EPILEPSY/therapy; HYDANTOINS/injurious effects; PHENOBARBITAL/injurious effects